This article is freely available to all

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: We read with interest the recent article by Melkersson1 that described the differential effect on prolactin elevation in schizophrenic patients treated with clozapine (none of the patients had elevated prolactin), olanzapine (24% of the patients had elevated prolactin), and risperidone (89% of the patients had elevated prolactin). Previous head-to-head clinical trials have revealed similar results.2-5 However, these comparison studies might be limited by the individual variation in endocrine profiles, demographic variables such as age and gender, and concomitant medication use.6,7‘ ‹